Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia.
Department of Paediatrics, Hospital Pulau Pinang, George Town, Malaysia.
Ann Neurol. 2024 Nov;96(5):932-943. doi: 10.1002/ana.27041. Epub 2024 Aug 2.
To understand the etiological landscape and phenotypic differences between 2 developmental and epileptic encephalopathy (DEE) syndromes: DEE with spike-wave activation in sleep (DEE-SWAS) and epileptic encephalopathy with spike-wave activation in sleep (EE-SWAS).
All patients fulfilled International League Against Epilepsy (ILAE) DEE-SWAS or EE-SWAS criteria with a Core cohort (n = 91) drawn from our Epilepsy Genetics research program, together with 10 etiologically solved patients referred by collaborators in the Expanded cohort (n = 101). Detailed phenotyping and analysis of molecular genetic results were performed. We compared the phenotypic features of individuals with DEE-SWAS and EE-SWAS. Brain-specific gene co-expression analysis was performed for D/EE-SWAS genes.
We identified the etiology in 42/91 (46%) patients in our Core cohort, including 29/44 (66%) with DEE-SWAS and 13/47 (28%) with EE-SWAS. A genetic etiology was identified in 31/91 (34%). D/EE-SWAS genes were highly co-expressed in brain, highlighting the importance of channelopathies and transcriptional regulators. Structural etiologies were found in 12/91 (13%) individuals. We identified 10 novel D/EE-SWAS genes with a range of functions: ATP1A2, CACNA1A, FOXP1, GRIN1, KCNMA1, KCNQ3, PPFIA3, PUF60, SETD1B, and ZBTB18, and 2 novel copy number variants, 17p11.2 duplication and 5q22 deletion. Although developmental regression patterns were similar in both syndromes, DEE-SWAS was associated with a longer duration of epilepsy and poorer intellectual outcome than EE-SWAS.
DEE-SWAS and EE-SWAS have highly heterogeneous genetic and structural etiologies. Phenotypic analysis highlights valuable clinical differences between DEE-SWAS and EE-SWAS which inform clinical care and prognostic counseling. Our etiological findings pave the way for the development of precision therapies. ANN NEUROL 2024;96:932-943.
了解两种发育性癫痫脑病(DEE)综合征(睡眠中出现棘慢波激活的 DEE-SWAS 和睡眠中出现棘慢波激活的癫痫性脑病 EE-SWAS)的病因景观和表型差异。
所有患者均符合国际抗癫痫联盟(ILAE)DEE-SWAS 或 EE-SWAS 标准,并纳入来自我们癫痫遗传学研究计划的核心队列(n=91),同时纳入 101 名合作研究者的扩展队列中病因明确的 10 名患者。对患者进行详细的表型分析和分子遗传学结果分析。我们比较了 DEE-SWAS 和 EE-SWAS 患者的表型特征。对 D/EE-SWAS 基因进行脑特异性基因共表达分析。
在我们的核心队列中,42/91(46%)名患者的病因得到了确定,其中 29/44(66%)例为 DEE-SWAS,13/47(28%)例为 EE-SWAS。31/91(34%)例患者的病因是遗传因素。D/EE-SWAS 基因在脑中高度共表达,突出了通道病和转录调节剂的重要性。12/91(13%)名患者存在结构性病因。我们确定了 10 个具有多种功能的新的 D/EE-SWAS 基因:ATP1A2、CACNA1A、FOXP1、GRIN1、KCNMA1、KCNQ3、PPFIA3、PUF60、SETD1B 和 ZBTB18,以及 2 个新的拷贝数变异,17p11.2 重复和 5q22 缺失。尽管两种综合征的发育倒退模式相似,但 DEE-SWAS 与癫痫持续时间更长和智力预后更差有关。
DEE-SWAS 和 EE-SWAS 具有高度异质性的遗传和结构性病因。表型分析突出了 DEE-SWAS 和 EE-SWAS 之间有价值的临床差异,这为临床护理和预后咨询提供了信息。我们的病因学发现为精准治疗的发展铺平了道路。神经病学年鉴 2024;96:932-943。